Details for Patent: 5,872,132

Title:	Form of paroxetine hydrochloride anhydrate
Abstract:	"Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated."
Inventor(s):	Ward; Neal (East Sussex, GB2), Jacewicz; Victor Witold (Kent, GB2)
Assignee:	SmithKline Beecham Corporation (Philadelphia, PA)
Filing Date:	Oct 18, 1996
Application Number:	08/733,874
Claims:	1. Paroxetine hydrochloride anhydrate in Form C, which form comprises the following characteristics: a melting point of about 164.degree. C.; IR bands at about 540, 574, 615, 674, 720, 760, 779, 802, 829, 840, 886, 935, 965, 984, 1007, 1034, 1092, 1109, 1139, 1183, 1218, 1240, 1263, 1280, 1507, 1540, 1558, 1598, and 1652 cm.sup.-1 ; a DSC maximum exotherm measured at 10.degree. C. per minute, of about 161.degree. C. in both open and closed pans; characteristic X-ray diffractogram peaks at about 10.1, 12.1, 13.1, 14.3 degrees 2 theta; characteristic solid state .sup.13 C-NMR spectrum peaks at about 154.0, 148.5, 143.4, 140.4 ppm. 2. A pharmaceutical composition comprising paroxetine hydrochloride anhydrate in Form C and a pharmaceutically acceptable carrier, which Form C comprises the following characteristics: a melting point of about 164.degree. C.; IR bands at about 540, 574, 615, 674, 720, 760, 779, 802, 829, 840, 886, 935, 965, 984, 1007, 1034, 1092, 1109, 1139, 1183, 1218, 1240, 1263, 1280, 1507, 1540, 1558, 1598, and 1652 cm.sup.-1 ; a DSC maximum exotherm, measured at 10.degree. C. per minute, of about 161.degree. C. in both open and closed pans; characteristic X-ray diffractogram peaks at about 10.1, 12.1, 13.1, 14.3 degrees 2 theta, characteristic solid state .sup.13 C-NMR spectrum peaks at about 154.0, 148.5. 143.4, 140.4 ppm.